Case 2 Analysis Outline Invitrogen is a leading consumables company in the life sciences space. The company has experiences success over the years and is always looking for opportunities of growth as well as capitalizing on the newest technology, in this case, they are wanting to be the leader in the cell biology market. Part D. COMPETITOR ANALYSIS:
1. Immediate Competition: Immediate competition includes Roche which competes not only financially, but was the first company to utilize a system which promised to sequence a human genome for a less amount of money than other companies in the field. Illumina later launched another gnome analyzer that had more accuracy and compatible costs. Finally Applied Biosystems enter the competition with a product called SOLiD which generated human genome technology at a much faster rate and increased the …show more content…
Does the Company have a core competence? Invitrogen is the leader in consumables within the life sciences space companies. It is one of the largest catalog life sciences companies in the industry with a consistent customer base who come from academic research, biotechnology, pharmaceutical companies, and government laboratories. Invitrogen is known for its very aggressive acquisition strategy thus allowing the company consistent growth as well as offering customers more of an array of products and services. The core competence of Invitrogen is that there is a collective learning within the organization centered around trying to acquire new technologies in order to diversify products and technologies.
2. Does the Company have a sustainable competitive advantage? a. Valuable Capabilities – The potential to enter a variety of markets all under the biosciences umbrella make Invitrogen a competitor in their field. They started with certain types of technologies and have acquired new technologies (companies) over time providing them with an array of products and
1. Immediate Competition: Immediate competition includes Roche which competes not only financially, but was the first company to utilize a system which promised to sequence a human genome for a less amount of money than other companies in the field. Illumina later launched another gnome analyzer that had more accuracy and compatible costs. Finally Applied Biosystems enter the competition with a product called SOLiD which generated human genome technology at a much faster rate and increased the …show more content…
Does the Company have a core competence? Invitrogen is the leader in consumables within the life sciences space companies. It is one of the largest catalog life sciences companies in the industry with a consistent customer base who come from academic research, biotechnology, pharmaceutical companies, and government laboratories. Invitrogen is known for its very aggressive acquisition strategy thus allowing the company consistent growth as well as offering customers more of an array of products and services. The core competence of Invitrogen is that there is a collective learning within the organization centered around trying to acquire new technologies in order to diversify products and technologies.
2. Does the Company have a sustainable competitive advantage? a. Valuable Capabilities – The potential to enter a variety of markets all under the biosciences umbrella make Invitrogen a competitor in their field. They started with certain types of technologies and have acquired new technologies (companies) over time providing them with an array of products and